The Trastuzumab biosimilar was developed in-house by the research team at the Zydus Research Centre (ZRC) and was first launched in India in 2016 under the brand name Vivitra. Since its launch ...
Zydus Cadila launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both Early and Advanced HER2 positive Breast Cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback